Copertina

EccDNA, STING activation, and their potential roles in DLBCL prognosis and therapy

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Xi‐Bo Hu, Wei‐Ying Wang, Xiao‐Jian Sun, Qun‐Ling Zhang
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2024
Soggetti:	Clinical and Translational Discovery
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

GPR183 ‐mediated activation of PI3K is a potential biomarker for immunotherapy in lung cancer
di: Ling Ye, et al.
Pubblicazione: (2026)

Challenges and advances of immune checkpoint therapy
di: Lingyu Li, et al.
Pubblicazione: (2024)

A vital step toward targeting lymph node metastasis: Identifying APOE− cells as prognostic drivers in papillary thyroid carcinoma
di: Ling Xiao, et al.
Pubblicazione: (2025)

scICB: A pan‐cancer database of human temporal immune checkpoint blockade therapy at single‐cell transcriptomic resolution
di: Fansen Ji, et al.
Pubblicazione: (2025)

Toward precision oncology: An integrative multi‐omics approach for prognosis prediction and inferred immunotherapy responsiveness in breast cancer
di: Houda Bendani, et al.
Pubblicazione: (2026)

CRISPR‐based gene therapy for wet age‐related macular degeneration in mouse model
di: Dongchun Xie, et al.
Pubblicazione: (2024)

Tracking down metabolic vulnerabilities in CDK12‐mutant prostate cancer
di: Wei‐Ling Tu, et al.
Pubblicazione: (2024)

Overcoming challenges in CAR‐T therapy for malignancies: Mechanisms and strategies
di: Yushan Huang, et al.
Pubblicazione: (2026)

Therapeutic potential of the annexin A family in atherosclerosis
di: Suha Jarad, et al.
Pubblicazione: (2025)

Exploring new frontiers in lung cancer treatment: The role of cancer‐associated fibroblasts (CAFs) and EGFR‐TKI resistance
di: Jiaqi Liang, et al.
Pubblicazione: (2025)

Mesenchymal stem cell therapy for ulcerative colitis: Opportunities and challenges in precision medicine
di: Peng‐Fei Wang, et al.
Pubblicazione: (2025)

Gastric cancer detection based on cell‐free DNA in blood: A systematic review and meta‐analysis
di: Mona Wang, et al.
Pubblicazione: (2024)

Cell‐free DNA‐associated multi‐feature applications in cancer diagnosis and treatment
di: Xiaolu Zhang, et al.
Pubblicazione: (2024)

Targeting mutated KRAS in the first‐line therapy
di: Hideaki Ijichi
Pubblicazione: (2024)

The role of T cells in sepsis of distinct infectious aetiologies
di: Xuanqi Liu, et al.
Pubblicazione: (2026)

Milk exosomes: Harnessing nature's duality for cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Engineered cell versus modified exosomes in cancer therapy
di: Rajib Dhar, et al.
Pubblicazione: (2024)

Evaluating the potential risks of employing large language models in peer review
di: Lingxuan Zhu, et al.
Pubblicazione: (2025)

Effects of microRNA on the growth and targeted therapy response on lung cancer
di: Mengchen Zhu, et al.
Pubblicazione: (2024)

Liquid biopsy—A biomarker‐based revolutionising technique in cancer therapy
di: Subham Sarkar, et al.
Pubblicazione: (2024)

Role of DNA methylation in cancer development and its clinical applications
di: Swarup Sonar, et al.
Pubblicazione: (2024)

Bacterial surface derived extracellular vesicles: A ground‐breaking approach in cancer therapy
di: Asmit Das, et al.
Pubblicazione: (2024)

Plant‐derived exosomes: A new frontier in nano‐medicine for cancer and microbial infection therapy
di: Swastika Maitra, et al.
Pubblicazione: (2024)

Sculpting nursing resilience: Transforming lives, nurturing ethics in chimeric antigen receptor T‐cell therapy
di: Pranay Bende
Pubblicazione: (2024)

A snapshot of the role of estrogen‐regulated divergent non‐coding transcripts
di: Barbara Yang, et al.
Pubblicazione: (2025)

CEACAM6: A potential prognostic biomarker and therapeutic target in cholangiocarcinoma
di: Jia‐Qi Guo, et al.
Pubblicazione: (2026)

Surufatinib plus anti‐PD‐1/PD‐L1 antibody as second‐line therapy for advanced biliary tract cancer: A single‐centre investigator‐initiated trial
di: Xinni Chen, et al.
Pubblicazione: (2026)

The SLC39A1‐DRP1 axis: A paradigm shift in targeting mitochondrial dynamics for HCC therapy
di: Jing Zhao, et al.
Pubblicazione: (2025)

Potential diagnostic and distinguishing roles of microneedle‐based biosensors in bacterial and aseptic meningitis
di: Hamid Sadeghi, et al.
Pubblicazione: (2024)

Current advances in the role of classical non‐homologous end joining in hematologic malignancies
di: Pengcheng Liu, et al.
Pubblicazione: (2025)

Periodontitis and extracellular vesicles: Emerging roles in inflammation, tissue destruction and systemic crosstalk
di: Mai Ahmed, et al.
Pubblicazione: (2026)

Precision treatment paradigm: Genomic features and therapeutic implications in mesenchymal‐epithelial transition‐amplified gastric cancer
di: Yiyi Yu, et al.
Pubblicazione: (2024)

Sticky situation, strategic strike: Targeting neutrophil extracellular trap‐work in cancer
di: Bo Cao, et al.
Pubblicazione: (2025)

The emerging role of CAMK1D in diabetes, metabolism and feeding behaviours: A mechanistic systematic review
di: Livio Tarchi, et al.
Pubblicazione: (2026)

From channel‐spatial attention to state space models: A review of evolving mechanisms in tumour segmentation
di: Yanfei Sun, et al.
Pubblicazione: (2026)

High expression of miR5700 in atypical type A thymoma and its role in promoting tumour progression
di: Li Zhao, et al.
Pubblicazione: (2026)

A comprehensive atlas of pediatric immune checkpoint inhibitors‐related adverse events: From real‐world pharmacovigilance data to mechanistic insights
di: Anqi Lin, et al.
Pubblicazione: (2025)

Physiology, pathology and therapeutic potential of microglial triggering receptor expressed on myeloid cells 2 signalling: A narrative update
di: Zhe Kong, et al.
Pubblicazione: (2026)

Alveolar IL1β + neutrophils: Emerging biomarkers and therapeutic targets in CARDS progression
di: Lu Jia, et al.
Pubblicazione: (2025)

Epigenetic regulation of Epstein–Barr virus: From bench to bedside
di: Xiao Gao, et al.
Pubblicazione: (2024)